High somatic mutations in circulating tumor DNA predict response of metastatic pancreatic ductal adenocarcinoma to first-line nab-paclitaxel plus S-1: prospective …
L Huang, Y Lv, S Guan, H Yan, L Han, Z Wang… - Journal of Translational …, 2024 - Springer
Aims We previously showed that the nab-paclitaxel plus S-1 (NPS) regimen had promising
effects against metastatic pancreatic ducal adenocarcinoma (mPDAC), whose efficacy …
effects against metastatic pancreatic ducal adenocarcinoma (mPDAC), whose efficacy …
A Review of Circulating Tumor DNA (ctDNA) in Pancreatic Cancer: Ready for the Clinic?
P Jonnalagadda, V Arnold, BA Weinberg - Journal of Gastrointestinal …, 2025 - Springer
Pancreatic ductal adenocarcinoma is a devastating disease which is associated with an
increase in cancer-related death in the USA. The minority of patients are cured by surgery …
increase in cancer-related death in the USA. The minority of patients are cured by surgery …
New Biomarkers to Define a Biological Borderline Situation for Pancreatic Adenocarcinoma: Results of an Ancillary Study of the PANACHE01-PRODIGE48 Trial
J Pinson, J Henriques, L Beaussire… - Annals of …, 2024 - journals.lww.com
Objective: To investigate in patients treated for a resectable pancreatic ductal
adenocarcinoma [pancreatic adenocarcinoma (PA)], the prognostic value of baseline …
adenocarcinoma [pancreatic adenocarcinoma (PA)], the prognostic value of baseline …
Utility of circulating plasma cell-free DNA for detection and quantification of brain arteriovenous malformations
M Zhang, S Zhao, L Yu, X Li, S Hu, C Wang, G Wang… - Nano Today, 2024 - Elsevier
Brain arteriovenous malformations (BAVMs) are primarily associated with somatic activating
pathogenic KRAS variants. KRAS-targeting therapy is emerging as a potential treatment for …
pathogenic KRAS variants. KRAS-targeting therapy is emerging as a potential treatment for …
Personalized decision making of neoadjuvant chemotherapy vs. upfront surgery in pancreatic cancer by a simple blood collection?
P Kirchweger, B Doleschal, H Rumpold… - memo-Magazine of …, 2024 - Springer
Pancreatic cancer still has dismal survival rates and high rates of early recurrence despite
improvements of multimodal treatment options and more and more aggressive surgical …
improvements of multimodal treatment options and more and more aggressive surgical …
[HTML][HTML] Das Potenzial von Liquid Biopsy in der Diagnostik und Früherkennung des Pankreaskarzinoms
LS mehr zu diesem Thema, LB bei Lungenkrebs - journalonko.de
25. Juni 2024 Das Potenzial von Liquid Biopsy in der Diagnostik und Früherkennung des
Pankreaskarzinoms© Jo Panuwat D-stock. adobe. com Das Pankreaskarzinom wird …
Pankreaskarzinoms© Jo Panuwat D-stock. adobe. com Das Pankreaskarzinom wird …